Picard Medical to Present Data on Next-Gen Artificial Heart at CSI Focus D-HF Conference

Picard Medical will present data on its next-generation Emperor Total Artificial Heart at the CSI Focus D-HF conference in Frankfurt, Germany. The presentation will highlight pre-clinical results, including stable hemodynamics and afterload independence. The company notes that the Emperor platform offers improved performance and patient independence. Revenue from SynCardia's Total Artificial Heart platform increased 11% YoY to $3.93 million in the first nine months of 2025.